WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027845) SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027845    International Application No.:    PCT/US1999/026447
Publication Date: 18.05.2000 International Filing Date: 08.11.1999
Chapter 2 Demand Filed:    01.06.2000    
IPC:
C07D 221/20 (2006.01), C07D 471/10 (2006.01), C07D 471/20 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US) (For All Designated States Except US).
BANYU PHARMACEUTICAL CO., LTD. [JP/JP]; 2-3, Nihombashi Honcho 2-chome, Chuo-ku, Tokyo 103-8416 (JP) (For All Designated States Except US).
GAO, Ying-Duo [CN/US]; (US) (For US Only).
MACNEIL, Douglas, J. [US/US]; (US) (For US Only).
YANG, Lihu [US/US]; (US) (For US Only).
MORIN, Nancy, R. [US/US]; (US) (For US Only).
FUKAMI, Takehiro [JP/JP]; (JP) (For US Only).
KANATANI, Akio [JP/JP]; (JP) (For US Only).
FUKURODA, Takahiro [JP/JP]; (JP) (For US Only).
ISHII, Yasuyuki [JP/JP]; (JP) (For US Only).
MORIN, Masaki [JP/JP]; (JP) (For US Only)
Inventors: GAO, Ying-Duo; (US).
MACNEIL, Douglas, J.; (US).
YANG, Lihu; (US).
MORIN, Nancy, R.; (US).
FUKAMI, Takehiro; (JP).
KANATANI, Akio; (JP).
FUKURODA, Takahiro; (JP).
ISHII, Yasuyuki; (JP).
MORIN, Masaki; (JP)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US)
Priority Data:
60/107,835 10.11.1998 US
Title (EN) SPIRO-INDOLINES AS Y5 RECEPTOR ANTAGONISTS
(FR) SPIRO-INDOLINES EN TANT QU'ANTAGONISTES DU RECEPTEUR Y5
Abstract: front page image
(EN)Compounds of general structural formula (I) such as that shown in structural formula (II) are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.
(FR)Composés de formule structurale générale (I) tels que ceux représentés par la formule (II), qui sont des antagonistes de récepteur NPY Y5, utiles pour traiter l'obésité et les complications associées.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)